Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening
Open Access
- 1 October 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (10), 1785-1796
- https://doi.org/10.1373/clinchem.2004.035907
Abstract
Background: Newborn screening for deficiency in the lysosomal enzymes that cause Fabry, Gaucher, Krabbe, Niemann–Pick A/B, and Pompe diseases is warranted because treatment for these syndromes is now available or anticipated in the near feature. We describe a multiplex screening method for all five lysosomal enzymes that uses newborn-screening cards containing dried blood spots as the enzyme source. Methods: We used a cassette of substrates and internal standards to directly quantify the enzymatic activities, and tandem mass spectrometry for enzymatic product detection. Rehydrated dried blood spots were incubated with the enzyme substrates. We used liquid-liquid extraction followed by solid-phase extraction with silica gel to remove buffer components. Acarbose served as inhibitor of an interfering acid α-glucosidase present in neutrophils, which allowed the lysosomal enzyme implicated in Pompe disease to be selectively analyzed. Results: We analyzed dried blood spots from 5 patients with Gaucher, 5 with Niemann–Pick A/B, 11 with Pompe, 5 with Fabry, and 12 with Krabbe disease, and in all cases the enzyme activities were below the minimum activities measured in a collection of heterozygous carriers and healthy noncarrier individuals. The enzyme activities measured in 5–9 heterozygous carriers were approximately one-half those measured with 15–32 healthy individuals, but there was partial overlap of each condition between the data sets for carriers and healthy individuals. Conclusion: For all five diseases, the affected individuals were detected. The assay can be readily automated, and the anticipated reagent and supply costs are well within the budget limits of newborn-screening centers.Keywords
This publication has 27 references indexed in Scilit:
- Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe DiseaseClinical Chemistry, 2004
- Niemann-Pick Disease Type A and B are Clinically but also Enzymatically Heterogeneous: Pitfall in the Laboratory Diagnosis of Sphingomyelinase Deficiency Associated with the Mutation Q292 KNeuropediatrics, 2003
- Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from NewbornsClinical Chemistry, 2003
- Enzyme Therapy for Lysosomal Storage Disease: Principles, Practice, and ProspectsAnnual Review of Genomics and Human Genetics, 2003
- Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapyMuscle & Nerve, 2003
- Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson‐Fabry diseaseRapid Communications in Mass Spectrometry, 2002
- Groups IV, V, and X Phospholipases A2s in Human NeutrophilsOnline Journal of Public Health Informatics, 2002
- New Prospects for the Treatment of Lysosomal Storage DiseasesDrugs, 2002
- Tris discriminates between the different α-glucosidase activities from extracts of human neutrophilsJournal of Inherited Metabolic Disease, 1992
- Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-α-glucosidase in human fetal and adult tissues and cultured cellsClinica Chimica Acta; International Journal of Clinical Chemistry, 1985